Clinical Trial Update: Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing Adderall XR with Concerta in pediatric cancer patients assessing memory, attention, and depression was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Neurotoxicity

Drugs mentioned

• Adderall XR (mixed amphetamine salts)
• CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

Sponsor: University of South Florida | Conditions: Depression, Neurotoxicity | Phase 2 | Status: TERMINATED